Development of Anti-CCP-positive Rheumatoid Arthritis Following Pegylated Interferon-α2a Treatment for Chronic Hepatitis C Infection [PDF]
DARICE YANG +2 more
openalex +1 more source
Adding pegylated interferon-α to nucleos(t)ide analogs improves HBsAg clearance in chronic hepatitis B with low-level viremia. [PDF]
Wang L +6 more
europepmc +1 more source
Retinal thrombosis secondary to the combination therapy of pegylated interferon and ribavirin for chronic hepatitis C virus infection: A rare complication [PDF]
Felipe Sahidt Ortega-Ibarra +1 more
openalex +1 more source
Correction: Efficacy and safety of pegylated interferon in the treatment of JAK2<sup>V617F</sup>-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study. [PDF]
Chang L, Li WX, Cai H, Li J, Duan MH.
europepmc +1 more source
Assessing the Impact of Pegylated-Interferon/Ribavirin Therapy Duration Versus Viral Response on Health-Related Quality of Life (Qol) Outcomes In Chronic Hepatitis C Virus (Hcv) Patients, Using Multivariate Mixed-Effects Modeling [PDF]
Pushpike Thilakarathne +3 more
openalex +1 more source
Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients [PDF]
Madiha Akram +10 more
openalex +1 more source
Impact of nonalcoholic fatty liver disease on the functional cure of nucleos(t)ide analogues-treated chronic hepatitis B patients add-on pegylated interferon therapy: a retrospective study. [PDF]
Li H +7 more
europepmc +1 more source
Organizing pneumonia in a patient following treatment of chronic hepatitis B with pegylated interferon alfa-2b: A case report. [PDF]
Tian B, Wang P, Shan C, Gao C, Zhang Q.
europepmc +1 more source

